Frédéric J. Zécri

2.4k total citations
33 papers, 1.4k citations indexed

About

Frédéric J. Zécri is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Frédéric J. Zécri has authored 33 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Frédéric J. Zécri's work include Chemical Synthesis and Analysis (6 papers), Sphingolipid Metabolism and Signaling (6 papers) and Synthetic Organic Chemistry Methods (5 papers). Frédéric J. Zécri is often cited by papers focused on Chemical Synthesis and Analysis (6 papers), Sphingolipid Metabolism and Signaling (6 papers) and Synthetic Organic Chemistry Methods (5 papers). Frédéric J. Zécri collaborates with scholars based in Switzerland, United States and China. Frédéric J. Zécri's co-authors include Danilo Guerini, Florian Müllershausen, Klaus Seuwen, Andreas Billich, Simone Bonazzi, Anthony G. M. Barrett, Kaila A. Margrey, Joshua B. McManus, David A. Nicewicz and Susan M. Cramp and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Diabetes.

In The Last Decade

Frédéric J. Zécri

32 papers receiving 1.4k citations

Peers

Frédéric J. Zécri
R. Nathan Daniels United States
Todd Bosanac United States
Matthew M. Hayward United States
Christopher H. Hill United Kingdom
Claudia Ruiz United States
John Wityak United States
Sang Min Lim South Korea
R. Nathan Daniels United States
Frédéric J. Zécri
Citations per year, relative to Frédéric J. Zécri Frédéric J. Zécri (= 1×) peers R. Nathan Daniels

Countries citing papers authored by Frédéric J. Zécri

Since Specialization
Citations

This map shows the geographic impact of Frédéric J. Zécri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric J. Zécri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric J. Zécri more than expected).

Fields of papers citing papers by Frédéric J. Zécri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric J. Zécri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric J. Zécri. The network helps show where Frédéric J. Zécri may publish in the future.

Co-authorship network of co-authors of Frédéric J. Zécri

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric J. Zécri. A scholar is included among the top collaborators of Frédéric J. Zécri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric J. Zécri. Frédéric J. Zécri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tan, Zher Yin, Michael Salcius, Bingqi Tong, et al.. (2025). Development of an FKBP12-recruiting chemical-induced proximity DNA-encoded library and its application to discover an autophagy potentiator. Cell chemical biology. 32(3). 498–510.e35. 6 indexed citations
2.
Tong, Bingqi, Zher Yin Tan, Antonin Tutter, et al.. (2025). Selectivity Profiling of Bromodomain PROTACs Using Chemical Inducers of Proximity DNA-Encoded Library Screening. ACS Chemical Biology. 20(9). 2266–2276.
3.
Tutter, Antonin, Gregory A. Michaud, Matthias V. Westphal, et al.. (2023). DNA-encoded library-enabled discovery of proximity-inducing small molecules. Nature Chemical Biology. 20(2). 170–179. 41 indexed citations
4.
Liu, Shuang, Bingqi Tong, J.M. Ostrem, et al.. (2023). Rational Screening for Cooperativity in Small-Molecule Inducers of Protein–Protein Associations. Journal of the American Chemical Society. 145(42). 23281–23291. 35 indexed citations
5.
Zécri, Frédéric J., et al.. (2022). Modular Synthesis of Cyclopropane‐Fused N‐Heterocycles Enabled by Underexplored Diazo Reagents. Angewandte Chemie International Edition. 61(38). e202203221–e202203221. 12 indexed citations
6.
Harrison, Tyler, Daniel Bauer, Xin Chen, et al.. (2019). Successful Strategies for Mitigation of a Preclinical Signal for Phototoxicity in a DGAT1 Inhibitor. ACS Medicinal Chemistry Letters. 10(8). 1128–1133. 6 indexed citations
7.
Gampe, Christian M., et al.. (2018). 3′-Modification stabilizes mRNA and increases translation in cells. Bioorganic & Medicinal Chemistry Letters. 28(14). 2451–2453. 7 indexed citations
8.
Hoegenauer, Klemens, Nicolas Soldermann, Frédéric J. Zécri, et al.. (2017). Discovery of CDZ173 (Leniolisib), Representing a Structurally Novel Class of PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 8(9). 975–980. 84 indexed citations
9.
Zhao, Peng, David O. Nettleton, Rajeshri G. Karki, Frédéric J. Zécri, & Shih‐Yuan Liu. (2017). Medicinal Chemistry Profiling of Monocyclic 1,2‐Azaborines. ChemMedChem. 12(5). 358–361. 97 indexed citations
10.
Hoegenauer, Klemens, Nicolas Soldermann, Gregory J. Hollingworth, et al.. (2016). Discovery of novel pyrrolidineoxy-substituted heteroaromatics as potent and selective PI3K delta inhibitors with improved physicochemical properties. Bioorganic & Medicinal Chemistry Letters. 26(23). 5657–5662. 17 indexed citations
11.
Zécri, Frédéric J.. (2016). From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?. Current Opinion in Chemical Biology. 32. 60–66. 22 indexed citations
12.
Hoegenauer, Klemens, Nicolas Soldermann, Frédéric Stauffer, et al.. (2016). Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective Inhibitors. ACS Medicinal Chemistry Letters. 7(8). 762–767. 49 indexed citations
13.
Gampe, Christian M., et al.. (2016). Covalent Chemical 5′‐Functionalization of RNA with Diazo Reagents. Angewandte Chemie International Edition. 55(35). 10283–10286. 18 indexed citations
14.
McKeown, Stephen C., et al.. (2014). The design and implementation of a generic lipopeptide scanning platform to enable the identification of ‘locally acting’ agonists for the apelin receptor. Bioorganic & Medicinal Chemistry Letters. 24(20). 4871–4875. 12 indexed citations
16.
Zécri, Frédéric J., Rainer Albert, Gregory A. Landrum, et al.. (2009). Pyrazole derived from (+)-3-carene; a novel potent, selective scaffold for sphingosine-1-phosphate (S1P1) receptor agonists. Bioorganic & Medicinal Chemistry Letters. 20(1). 35–37. 6 indexed citations
17.
Müllershausen, Florian, et al.. (2009). Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nature Chemical Biology. 5(6). 428–434. 306 indexed citations
19.
Barrett, Amy, Susan M. Cramp, Richard S. Roberts, & Frédéric J. Zécri. (2000). Chromatography-Free Synthesis of 1,2,4-Oxadiazoles Using ROMPGEL-Supported Acylating Reagents. Combinatorial Chemistry & High Throughput Screening. 3(2). 131–138. 14 indexed citations
20.
Arnauld, Thomas, Anthony G. M. Barrett, Susan M. Cramp, Richard S. Roberts, & Frédéric J. Zécri. (2000). ROMPGEL Scavengers:  A High-Loading Supported Anhydride for Sequestering Amines and Hydrazines. Organic Letters. 2(17). 2663–2666. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026